Conflict of interest statement: TK received research materials from Convatec, no financial funding. This does not alter our adherence to PLOS ONE policies onsharing data and materials. None of the authors served or currently serve on the editorial board of PLOS ONE. None of the authors acted as an expert witness inrelevant legal proceedings. None of the authors have sat or currently sit on acommittee for an organization that may benefit from publication of the paper.99. Rom J Intern Med. 2018 May 21. pii:/j/rjim.ahead-of-print/rjim-2018-0015/rjim-2018-0015.xml. doi:10.2478/rjim-2018-0015. [Epub ahead of print]Malignancy in a retrospective cohort of 17 patients with Dermatomyositis orPolymyositis in southern Tunisia.Sellami K(1), Mseddi M(1), Snoussi M(2), Gharbi H(1), Frikha F(2), Ben SalahR(2), Jallouli M(2), Marzouk S(2), Masmoudi A(1), Bahloul Z(2), Turki H(1).Author information: (1)Dermatology Department, Hedi Chaker University Hospital, Sfax, Tunisia.(2)Internal Medicine Department, Hedi Chaker University Hospital, Sfax, Tunisia.INTRODUCTION: The prognosis of dermatomyositis (DM)/polymyositis (PM) in adultsis partly related to their association with neoplasia. The aim of our study wasto report the epidemiologic, clinical, paraclinical, therapeutic and evolutionaryaspects of DM associated with malignancy in patients from Sfax, south eastern of Tunisia.METHODS: A retrospective cohort study of patients with DM or PM admitted inDermatology and Internal Medicine Departments of Hedi Chaker University Hospital of Sfax between 1996 and 2015. Cases of DM or PM associated with malignancy were retained.RESULTS: Seventeen cases (13.5%) of DM or PM were associated with malignancy werenoted. Fourteen patients had DM and 3 patients had PM. The Sex ratio M / F was0.3 and the mean age at diagnosis was 56.5 years. In DM patients, malignancypreceded the myositis in 64.2% of cases. In PM patients, only one patient wasknown to have breast cancer and the myositis revealed the cancer for the 2others. Treatment consisted on corticosteroids associated with methotrexate in 4 cases. Outcome was fatal in 5 cases (29.4%), due to the underlying cancer in 3cases. Swallowing disorders related to DM/PM were responsible of death in 2cases.CONCLUSION: There are no specific clinical or biological features inparaneoplastic DM. In our series, breast neoplasm represented the first cancerassociated with DM. Cancers of nasopharynx, colon and urinary tract had thesecond position.DOI: 10.2478/rjim-2018-0015 PMID: 29791319 